Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Other Non-Current Liabilities (2016 - 2025)

Healthstream (HSTM) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 277.49% to $7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.9 million, a 277.49% increase, with the full-year FY2025 number at $7.9 million, up 277.49% from a year prior.
  • Other Non-Current Liabilities was $7.9 million for Q4 2025 at Healthstream, up from $2.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $7.9 million in Q4 2025 to a low of $1.5 million in Q2 2022.
  • A 5-year average of $2.4 million and a median of $2.2 million in 2023 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: surged 521.29% in 2021, then plummeted 59.98% in 2022.
  • Healthstream's Other Non-Current Liabilities stood at $1.5 million in 2021, then soared by 49.63% to $2.2 million in 2022, then increased by 3.21% to $2.3 million in 2023, then dropped by 7.89% to $2.1 million in 2024, then skyrocketed by 277.49% to $7.9 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Other Non-Current Liabilities are $7.9 million (Q4 2025), $2.0 million (Q3 2025), and $2.0 million (Q2 2025).